This finding was inconsistent with the diagnosis of claudin mutations, as significant nephrocalcinosis, which can lead to end-stage renal disease, is well documented in patients with claudin mutations.22 Therefore, our differential diagnoses were narrowed down to CaSR mutation and primary hypoparathyroidism, both of which could have overlapping features. The gene discussed is CASR; the disease is nephrocalcinosis.